HIND Vyome Therapeutics: רווח נקי למניה ב-12 החודשים האחרונים

Strategic asset restructuring and proprietary developments at Vyome Holdings Inc (HIND) ensure business resilience. This YoY ttm earnings per share chart confirms this trend, where the value of 99.50 serves as the current metric. Meanwhile, the company is implementing eco-friendly chemical disposal methods, although it faces severe pricing pressure in the gastric systems segment.
פילוחי מדדים פיננסיים ומדדי שוק עבור Vyome Holdings Inc (HIND)

This indicator measures the earnings per share (EPS) dynamics over the last twelve months relative to the same period last year. The historical EPS YoY TTM delta allows for the rapid tracking of financial momentum by eliminating reporting time lags. For Vyome Holdings Inc (HIND), such volatility often reflects the efficiency of managing external CRO and CMO contractors. Sharp spikes in the curve may mask operational outsourcing risks, while a stable trend confirms the resilience of the business model.